| Literature DB >> 35847525 |
Stephanie Jansen-Kosterink1,2, Marijke Broekhuis1,2, Lex van Velsen1,2.
Abstract
It is challenging to design a proper eHealth evaluation. In our opinion, the evaluation of eHealth should be a continuous process, wherein increasingly mature versions of the technology are put to the test. In this article, we present a model for continuous eHealth evaluation, geared towards technology maturity. Technology maturity can be determined best via Technology Readiness Levels, of which there are nine, divided into three phases: the research, development, and deployment phases. For each phase, we list and discuss applicable activities and outcomes on the end-user, clinical, and societal front. Instead of focusing on a single perspective, we recommend to blend the end-user, health and societal perspective. With this article we aim to contribute to the methodological debate on how to create the optimal eHealth evaluation design.Entities:
Keywords: continuous process; design; eHealth; evaluation; perspectives; technology readiness level
Year: 2022 PMID: 35847525 PMCID: PMC9280845 DOI: 10.1177/20552076221113396
Source DB: PubMed Journal: Digit Health ISSN: 2055-2076
Figure 1.Technology readiness level scale.
An overview of the activities on the end-user, health, and societal perspective for the research, development, and deployment phase.
| End-user perspective | Health perspective | Societal perspective | ||
|---|---|---|---|---|
| Research phase | TRL 1 | Testing of basic principles with relevant stakeholders. | ||
| TRL 2 | Testing of basic concept to obtain fit between use and technology. | |||
| TRL 3 | Identifying the merits of the technology. | |||
| Development phase | TRL 4 | Small scale usability/UX studies in a lab setting, to test prototype components. | ||
| TRL 5 | Small scale usability/UX studies in a lab setting, to test integrated system | |||
| TRL 6 | Clinical study to the use, acceptance and potential health benefits of the technology within the daily clinical context. | |||
| Deployment phase | TRL 7 | Large scale clinical study to the use, acceptance, health benefits, and safety of the technology within the daily clinical context. | Discussions with relevant stakeholders to assess the forecast of financial and extra-financial value. | |
| TRL 8 | Long term monitoring of the health benefits and safety of the technology within the broad clinical context. | Strengthen the model of financial and extra-financial-value with the outcomes of clinical studies | ||
| TRL 9 | Strengthen model of financial and extra-financial-value with the outcomes of long term monitoring. |